Kyocera Unveils Custom 3D Printing ‘CAM’ for Prototype Medical Devices at MD&M West | New
ANAHEIM from California, August 10, 2021 / PRNewswire-PRWeb / – Kyocera, A Leader in Ceramic-Based Medical Devices, To Unveil Its Custom 3D Printing Service “CAM” (Ceramic Additive Manufacturing) for Profitable Prototypes of New Medical Device Designs at MD&M West Medical Expo To Anaheim, California, August 10-12, the world’s largest annual convention for designers and manufacturers of medical products. Kyocera’s new service uses both zirconia and alumina materials in a wide variety of shapes, a size range of 200 x 105 x 40mm, and a wall thickness of 0.25-10mm. The simple 3-step process produces samples quickly: simply send in a 3D CAD file, do a consultation the next day, then prototypes are created in 1 to 2 weeks *. In addition, Kyocera will also showcase its wide range of ceramic-based medical technologies at the exhibition.
Quick custom samples with CAM
Incorporating over 60 years of product development expertise, Kyocera engineers consult on each new project and design the most cost effective method for a 3D printed prototype of new medical device designs. Through this consultation and 3D printing using zirconia and alumina, Kyocera is able to produce virtually any type of custom prototype within 1 to 2 weeks. Ceramics from Kyocera offer scratch resistance, higher stiffness, temperature resistance, longer life, high voltage insulation, lighter weight and superior thermal management, delivering a lower overall cost of ownership . 3D capabilities include:
- Shapes: curves, square, angular, sharp edges, angular holes, negative draft, threads, textures, small holes
- Materials: Zirconia, Alumina
- Dimensions: 200 x 105 x 40 mm
- Tolerance: +/- 0.050 mm (when fired)
- Wall thickness: 0.25 – 10 mm
- Lock set
- Smooth surface
Additive Manufacturing and more @ Kyocera Stand # 2363 MD&M West
According to MD&M West, the global medical device manufacturing market is expected to overtake $ 200 billion by 2025, largely due to an aging population, chronic disease, and technological advancements to help a variety of ailments. Kyocera continues to use its unique “superhero” ceramic materials to advance medical technology. The company’s fine ceramics provide a very strong and durable non-reactive material that can be found in solutions for genetic sequencing; microfluidic tools; X-ray, PET, MRI and CT machines; pacemakers and heart monitors; neuromodulation devices; surgical tools; drug screening devices and orthopedic joint replacement systems. Information on these and more innovative medical ceramic solutions will be on display at Kyocera’s booth throughout the show.
Click to learn more about Kyocera medical solutions. To schedule a dedicated booth meeting or for more information on “CAM”, please send an email to [email protected]
* Fast production in 7-14 days if hard grinding or polishing is not required. The production schedule for each project will be estimated on the basis of a consultation.
Kyocera Company (TOKYO: 6971), the parent company and world headquarters of the Kyocera Group, was founded in 1959 as a producer of fine ceramics (also known as “advanced ceramics”). By combining these engineering materials with metals and integrating them with other technologies, Kyocera has become a leading supplier of industrial and automotive components, semiconductors, electronic devices, smart energy systems, printers, copiers and mobile phones. During the year ended March 31, 2021, the consolidated turnover of the company amounts to 1.5 trillion yen (about. US $ 13.8 billion). Kyocera is ranked 603 on Forbes Magazine’s 2021 “Global 2000” list of the world’s largest publicly traded companies, and is on the Wall Street Journal’s latest list of the “100 Most Sustainably Managed Companies in the World”.
Leasa Ireland, Kyocera, +1 3107507082, [email protected]